Manabu Katou

USPTO Granted Patents = 19 (Patent Applications = 2)

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 5 (Patent Applications = 4)

Average Co-Inventor Count = 3.7

ph-index = 8

Forward Citations = 181(Granted Patents)

Location History:

Kusatsu, JP (2008 - 2013)
Osaka, JP (2013 - 2019)
Toyonaka, JP (2014 - 2019)

Company Filing History:

10 out of 4,270

Daikin Industries, Ltd.

patents

9 out of 1,001

Shionogi Company Limited

patents

1 out of 1,281

The University of Tokyo

where one patent can have more than one assignee

Years Active: 2008-2025

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12227509 - Dihydropyrazolopyrazinone derivative having MGAT2 inhibitory activity (2025-02-18),

2. 10233156 - 9-membered fused ring derivative (2019-03-19),

3. 10189843 - Fused pyrazole derivative having autotaxin inhibitory activity (2019-01-29),

4. 10150728 - Alkylene derivatives (2018-12-11),

5. 10093670 - Azabenzimidazole derivative having AMPK-activating activity (2018-10-09),

6. 9567330 - Azabenzimidazole derivative having AMPK-activating activity (2017-02-14),

7. 9133186 - Hetero ring-fused imidazole derivative having AMPK activating effect (2015-09-15),

8. 8957219 - Acetic acid amide derivative having inhibitory activity on endothelial lipase (2015-02-17),

9. 8754113 - Oxadiazole derivative having endothelial lipase inhibitory activity (2014-06-17),

10. D683838 - Grille of outdoor unit for air-conditioner (2013-06-04),

11. D683835 - Outdoor unit for air-conditioner (2013-06-04),

12. D683834 - Outdoor unit for air-conditioner (2013-06-04),

13. D601237 - Air conditioner (2009-09-29),

14. D593664 - Air conditioner (2009-06-02),

15. D586454 - Fan duct for air conditioner (2009-02-10),

Title: The Innovative Journey of Manabu Katou

Introduction

Manabu Katou, based in Osaka, Japan, is a renowned inventor with a notable portfolio of 19 patents. His work primarily focuses on innovative compounds with significant pharmaceutical applications. With a strong background in the industry, Katou has made remarkable contributions to the field of medicinal chemistry.

Latest Patents

Among his latest patents is a dihydropyrazolopyrazinone derivative known for its MGAT2 inhibitory activity. This compound, represented by a specific formula, demonstrates potential in addressing metabolic disorders. Another significant innovation involves a compound aimed at providing novel ACC2 selective inhibitory activity. The pharmaceutical composition derived from this compound may have far-reaching implications in therapeutic applications.

Career Highlights

Throughout his career, Manabu Katou has been affiliated with prominent companies such as Daikin Industries, Ltd. and Shionogi & Company Limited. His expertise in the realm of medicinal chemistry has allowed him to contribute effectively to the development of groundbreaking drug candidates.

Collaborations

Katou has collaborated with several notable professionals, including Kaichi Tsuji and Masahiko Chouji. These partnerships have fostered a creative environment conducive to innovation, leading to the successful development of various patented compounds.

Conclusion

Manabu Katou's enduring passion for innovation and his extensive patent portfolio underscore his impact on the pharmaceutical industry. As he continues to explore new avenues in medicinal chemistry, his contributions are expected to advance therapeutic strategies and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.